1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Outset Medical, Inc.

Outset Medical, Inc.

OM
Outset Medical, Inc.US flagNASDAQ Global Select
3.59
USD
+0.03
- -
66.55MMarket Cap

Total Valuation

Outset Medical, Inc. carries a market capitalization of 66.55M, placing it among publicly traded companies globally. Its enterprise value stands at 38.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap66.55M
Enterprise Value38.46M

Share Statistics

Outset Medical, Inc. currently has 18.80M shares outstanding.

Shares Outstanding18.80M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.67, and the price-to-book ratio stands at 0.84.

PE RatioN/A
PS Ratio0.67
PB Ratio0.84
P/TBV Ratio0.84
P/FCF Ratio-2.08
P/OCF Ratio-2.05

Enterprise Valuation

EV / Sales0.33
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Outset Medical, Inc. maintains a current ratio of 5.19, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 108.42, indicating elevated leverage, while an interest coverage ratio of -4.57 demonstrates limited ability to service its debt obligations.

Current Ratio5.19
Quick Ratio4.02
Debt / Equity108.42
Debt / EBITDA-1.67
Interest Coverage-4.57

Financial Efficiency

Return on Equity (ROE)-60.09
Return on Assets (ROA)-27.97
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.38

Taxes

Income Tax936,000.00
Effective Tax RateN/A

Stock Price Statistics

Outset Medical, Inc.'s stock has declined approximately -74.00434% over the past 52 weeks. The 50-day moving average sits at 4.41, while the 200-day moving average is 4.26.

Beta (5Y)N/A
52-Week Price Change-74.00434%
50-Day Moving Average4.41
200-Day Moving Average4.26
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Outset Medical, Inc. generated 117.80M in revenue and converted that into -74.29M in net income, yielding earnings per share of -4.09. EBITDA reached -62.72M, while operating income came in at -66.04M.

Revenue117.80M
Gross Profit49.20M
Operating Income-66.04M
Pretax Income-73.35M
Net Income-74.29M
EBITDA-62.72M
EBIT-66.04M
Earnings Per Share (EPS)-4.09

Balance Sheet

Outset Medical, Inc. holds 147.19M in cash and equivalents against 104.45M in total debt, resulting in a net debt position of 62.64M. Total book value stands at 96.34M, with working capital of 183.96M providing operational flexibility.

Cash & Cash Equivalents147.19M
Total Debt104.45M
Net Debt62.64M
Equity (Book Value)96.34M
Book Value Per Share5.13
Working Capital183.96M

Cash Flow

Outset Medical, Inc. produced -38.32M in operating cash flow over the past twelve months. After subtracting -559,000.00 in capital expenditures, free cash flow totaled -38.88M - equivalent to -2.14 per share.

Operating Cash Flow-38.32M
Capital Expenditures-559,000.00
Free Cash Flow-38.88M
FCF Per Share-2.14

Margins

Outset Medical, Inc. operates with a gross margin of 41.76, reflecting its pricing power and cost economics. The operating margin of -56.06 and net profit margin of -63.06 provide insight into operational efficiency.

Gross Margin41.76
Operating Margin-56.06
Pretax Margin-62.27
Profit Margin-63.06
EBITDA Margin-53.24

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.79
FCF Yield-48.16

Stock Splits

Outset Medical, Inc.'s most recent stock split took place on March 20, 2025 with a 15:1 split ratio.

Last Split Date3/20/2025
Split Ratio15:1

Scores

Outset Medical, Inc. posts an Altman Z-Score of -6.15, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-6.15